Antibody-drug conjugates (ADCs) - Synthon
In the antibody-drug conjugation (ADC) approach, highly toxic molecules are attached to highly specific antibodies thereby increasing their tumor cell-killing capability.
ADC, antibody-drug conjugates, tumor cell-killing, linker technology, multi-drug resistant models, SpaceLink, duocarmycin, synthon, ADC therapy
Is this your site? Certify your site and update informations
